ESPR Change in Working Capital
Esperion Therapeutics Inc · Change in Working Capital
ESPR Change in Working Capital
Latest reported-$1.06Mperiod ending
ESPR Quarterly Change in Working Capital (-$513.33K → -$1.06M)
Quarterly change in working capital
High-resolution chart · PNG
ESPR change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -1,057,000 | |
| -21,325,000 | |
| 20,967,000 | |
| -26,312,000 | |
| 12,028,000 | |
| -21,308,000 | |
| -12,420,000 | |
| -4,999,000 | |
| -21,803,000 | |
| 3,955,000 | |
| 6,579,000 | |
| 10,160,000 | |
| -7,019,000 | |
| -2,213,000 | |
| -3,027,000 | |
| 301,000 | |
| 1,566,000 | |
| -5,584,000 | |
| -16,288,000 | |
| -21,279,000 | |
| -9,362,000 | |
| 9,031,000 | |
| -13,585,000 | |
| 2,647,000 | |
| -2,355,000 | |
| 1,429,000 | |
| -48,000 | |
| -6,360,000 | |
| -2,320,000 | |
| 24,527,000 | |
| 6,899,000 | |
| 803,000 | |
| -3,073,000 | |
| -1,603,000 | |
| 4,264,000 | |
| 11,955,000 | |
| 1,850,000 | |
| 8,750,000 | |
| -958,000 | |
| 2,294,000 | |
| -105,000 | |
| -95,000 | |
| -2,684,000 | |
| 661,000 | |
| 29,000 | |
| 82,000 | |
| 104,000 | |
| 2,118,000 | |
| -2,053,000 | |
| 1,569,767 | |
| 53,898 | |
| 974,729 | |
| 629,440 | |
| -432,531 | |
| 179,346 | |
| -37,090 | |
| -549,896 | |
| -1,108,000 | |
| 1,754,000 | |
| -150,000 | |
| 465,000 | |
| -389,000 | |
| 69,000 | |
| -610,000 | |
| -468,000 | |
| 210,000 | |
| -348,000 | |
| -459,000 | |
| -1,037,000 | |
| 2,955,000 | |
| 1,570,327 | |
| -513,327 |